0.369
price up icon21.10%   0.0643
after-market アフターアワーズ: .37 0.001 +0.27%
loading
前日終値:
$0.3047
開ける:
$0.3047
24時間の取引高:
2.37M
Relative Volume:
2.33
時価総額:
$24.39M
収益:
-
当期純損益:
$-30.01M
株価収益率:
-0.3025
EPS:
-1.22
ネットキャッシュフロー:
$-23.94M
1週間 パフォーマンス:
+34.38%
1か月 パフォーマンス:
+40.14%
6か月 パフォーマンス:
-63.10%
1年 パフォーマンス:
-64.52%
1日の値動き範囲:
Value
$0.3001
$0.4042
1週間の範囲:
Value
$0.2621
$0.41
52週間の値動き範囲:
Value
$0.217
$2.48

In 8 Bio Inc Stock (INAB) Company Profile

Name
名前
In 8 Bio Inc
Name
セクター
Healthcare (1182)
Name
電話
(646) 600-6438
Name
住所
EMPIRE STATE BUILDING, NEW YORK
Name
職員
39
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
INAB's Discussions on Twitter

In 8 Bio Inc Stock (INAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-08-30 開始されました H.C. Wainwright Buy

In 8 Bio Inc (INAB) 最新ニュース

pulisher
04:43 AM

Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success through Patient Affordability - Quantisnow

04:43 AM
pulisher
Nov 04, 2024

2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference - StockTitan

Nov 04, 2024
pulisher
Oct 31, 2024

bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies - Yahoo Finance

Oct 31, 2024
pulisher
Oct 25, 2024

OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of INmune Bio Inc Shares - Yahoo Finance UK

Oct 25, 2024
pulisher
Oct 23, 2024

Upstream Bio Rings the Opening Bell - Nasdaq

Oct 23, 2024
pulisher
Oct 23, 2024

Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - Yahoo Finance UK

Oct 23, 2024
pulisher
Oct 23, 2024

TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - Yahoo Finance

Oct 23, 2024
pulisher
Oct 18, 2024

MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum - Lelezard

Oct 18, 2024
pulisher
Oct 17, 2024

Average rate on a 30-year mortgage in the US rises to the highest level in 8 weeks - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Cresco Labs to Report Third Quarter 2024 Financial Results on November 8, 2024 - Yahoo Finance

Oct 17, 2024
pulisher
Oct 17, 2024

Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga

Oct 17, 2024
pulisher
Oct 17, 2024

State Street Corp's Strategic Reduction in Cabaletta Bio Inc Holdings - Yahoo Finance

Oct 17, 2024
pulisher
Oct 16, 2024

Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? - Yahoo Finance

Oct 16, 2024
pulisher
Oct 15, 2024

FDA Clears Annovis to Launch Pivotal Phase 3 Alzheimer's Studies, Paving the Way to NDAs - Quantisnow

Oct 15, 2024
pulisher
Oct 14, 2024

Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock? - Yahoo Finance

Oct 14, 2024
pulisher
Oct 10, 2024

Upstream Bio Leads Life Sciences IPOs With Upsized Listing - BNN Bloomberg

Oct 10, 2024
pulisher
Oct 10, 2024

Covid-Shot Maker Goes Bankrupt After Trailing Pfizer, Moderna - MSN

Oct 10, 2024
pulisher
Oct 09, 2024

Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35 - Insider Monkey

Oct 09, 2024
pulisher
Oct 08, 2024

Cellipont Bioservices and Mongoose Bio Sign Agreement to Advance MGB-001, its Lead TCR-T therapy, towards the Clinic for Multiple Cancers - Longview News-Journal

Oct 08, 2024
pulisher
Oct 08, 2024

Jim Wilson’s new gene therapy company Gemma is getting up to $100M from Brazil - The Philadelphia Inquirer

Oct 08, 2024
pulisher
Oct 08, 2024

Paramount Global to Report Third Quarter Financial Results on November 8, 2024 - Yahoo Finance

Oct 08, 2024
pulisher
Oct 07, 2024

SK Bioscience's U.S.-based bio company 'Pina Bio'It announced on the 8th that it has signed a contra.. - 매일경제

Oct 07, 2024
pulisher
Oct 07, 2024

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - BioSpace

Oct 07, 2024
pulisher
Oct 03, 2024

Adicet Bio, Inc.'s (NASDAQ:ACET) large institutional owners must be happy as stock continues to impress, up 11% over the past week - Simply Wall St

Oct 03, 2024
pulisher
Oct 02, 2024

If you bought this Breyers ice cream flavor in the past 8 years, you may be eligible for compensation - Yahoo Finance

Oct 02, 2024
pulisher
Sep 30, 2024

Gossamer Bio, Inc. (NASDAQ:GOSS) Short Interest Down 5.8% in September - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Adicet Bio to Present at the American Society of Gene & Cell Therapy’s (ASGCT) 2024 Advancing Gene + Cell Therapies for Cancer Conference - Business Wire

Sep 30, 2024
pulisher
Sep 27, 2024

A group of women lowered their biological age by an average of 5 years in just 8 weeks. Here’s how - Yahoo Finance

Sep 27, 2024
pulisher
Sep 25, 2024

Biomarker Data from Oncology Trial for Adicet Bio’s Game Delta T-cell Therapy ADI-001 Indicates Potential for Use in Autoimmune Disease - CGTLive™

Sep 25, 2024
pulisher
Sep 24, 2024

bluebird bio Initiates Restructuring Intended to Optimize Cost Structure and Enable Quarterly Cash Flow Break-Even in the Second Half of 2025 - Business Wire

Sep 24, 2024
pulisher
Sep 24, 2024

Analysts’ Weekly Ratings Changes for Adicet Bio (ACET) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Bluebird Bio to Cut 25% of Staff Amid Gene Therapy Struggles - BNN Bloomberg

Sep 24, 2024
pulisher
Sep 23, 2024

Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference - ForexTV.com

Sep 23, 2024
pulisher
Sep 20, 2024

Cigna scaling back Medicare Advantage footprint in 8 states next year - Yahoo Finance

Sep 20, 2024
pulisher
Sep 17, 2024

8x8 Inc executive sells over $25k in company stock By Investing.com - Investing.com South Africa

Sep 17, 2024
pulisher
Sep 17, 2024

8x8 CEO sells over $48k in company stock By Investing.com - Investing.com UK

Sep 17, 2024
pulisher
Sep 17, 2024

New insider Divincenzo Jonathan P. claimed no ownership of stock in the company (SEC Form 3) - Quantisnow

Sep 17, 2024
pulisher
Sep 17, 2024

Retina Society 2024: Population pharmacokinetic modeling and simulation of ocular clearance of aflibercept 8 mg and 2 mg - Ophthalmology Times

Sep 17, 2024
pulisher
Sep 16, 2024

SEC Form 424B5 filed by INmune Bio Inc. - Quantisnow

Sep 16, 2024
pulisher
Sep 14, 2024

Indian Immunologicals Signs Pact For Clinical Development Of Zika Vaccine - Afternoon Voice

Sep 14, 2024
pulisher
Sep 14, 2024

Indian Immunologicals Sign Pact For Clinical Development Of Zika Vaccine - NDTV

Sep 14, 2024
pulisher
Sep 13, 2024

Seven Aussie startups that raised $206 million this week (sort of) - SmartCompany

Sep 13, 2024
pulisher
Sep 11, 2024

Owning 41% shares,institutional owners seem interested in Nuvation Bio Inc. (NYSE:NUVB), - Simply Wall St

Sep 11, 2024
pulisher
Sep 10, 2024

SEC Form 4 filed by EVP, President, LSG Barry James - Quantisnow

Sep 10, 2024
pulisher
Sep 10, 2024

Biotech startup Number 8 Bio bags $7 million to drive methane-busting mission - SmartCompany

Sep 10, 2024
pulisher
Sep 05, 2024

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Sep 05, 2024
pulisher
Sep 04, 2024

Chairman, President, and CEO Schwartz Norman D covered exercise/tax liability with 5,159 units of Bio-Rad A Common Stock and converted options into 10,477 units of Bio-Rad A Common Stock, increasing direct ownership by 1% to 438,238 units (SEC For - Quantisnow

Sep 04, 2024
pulisher
Sep 04, 2024

Director Allison Schwartz converted options into 247 units of Bio-Rad A Common Stock and covered exercise/tax liability with 118 units of Bio-Rad A Common Stock, increasing direct ownership by 11% to 1,305 units (SEC Form 4) - Quantisnow

Sep 04, 2024
pulisher
Sep 04, 2024

Natco Pharma invests USD 8 mn in bio-tech firm eGenesis - Business Standard

Sep 04, 2024
pulisher
Sep 03, 2024

INmune Bio Inc. to Present at the Baird 2024 Global Healthcare Conference - StockTitan

Sep 03, 2024

In 8 Bio Inc (INAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):